In-San Kim
Affiliations: | 1978-2014 | Biochemistry & Cell Biology | Kyungpook National University, Daegu, South Korea |
| 1993-1993 | Dermatology | Jefferson Medical College, Philadelphia, PA, United States | |
| 1994-1996 | Molecular Genetics | University of Texas M. D. Anderson Cancer Center | |
| 2014- | Biomedical Research Institute | Korea Institute of Science and Technology, Daejeon, South Korea |
Website:
http://kist-ims.com/Google:
"In-San Kim"Parents
Sign in to add mentor| Benoit de Crombrugghe | post-doc | 1994-1996 | University of Texas M. D. Anderson Cancer Center (Chemistry Tree) |
| Sankar N. Maity | post-doc | 1994-1996 | University of Texas M. D. Anderson Cancer Center (Cell Biology Tree) |
Children
Sign in to add trainee| Eun Jung Lee | post-doc | 2014-2017 | Korea Institute of Science and Technology |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ahn W, Han J, Kim N, et al. (2025) Hierarchical protein nano-crystalline hydrogel with extracellular vesicles for ectopic lymphoid structure formation. Biomaterials. 318: 123166 |
| Kim GB, Kim S, Hwang YH, et al. (2023) Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy. Small (Weinheim An Der Bergstrasse, Germany). e2300527 |
| Kim SA, Lee Y, Ko Y, et al. (2022) Protein-based nanocages for vaccine development. Journal of Controlled Release : Official Journal of the Controlled Release Society. 353: 767-791 |
| Kim SA, Kim S, Kim GB, et al. (2022) A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations. International Journal of Molecular Sciences. 23 |
| Lee NK, Choi JU, Kim HR, et al. (2021) Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer. Biomaterials. 277: 121105 |
| Hong Y, Kim IS. (2021) The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer. Bmb Reports |
| Choi Y, Nam GH, Kim GB, et al. (2021) Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity. Cancer Gene Therapy |
| Kim GB, Sung HD, Nam GH, et al. (2021) Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Je H, Nam GH, Kim GB, et al. (2021) Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Yoo JD, Bae SM, Seo J, et al. (2020) Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy. Scientific Reports. 10: 19997 |